NEW YORK (GenomeWeb News) – GenMark Diagnostics reported after the close of the market Tuesday that its second-quarter revenues increased 300 percent due to growth in its test menu and reagents sold.

The Carlsbad, Calif.-based molecular diagnostics firm brought in total revenues of $3.6 million for the three months ended June 30, compared to $901,000 for the second quarter of 2011. It beat the consensus Wall Street estimate of $3.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.